In 1828, Abercrombiel published the first clinicopathological description of a case of puerperal cerebral venous thrombosis (CVT). Since then, the association of CVT with pregnancy and puerperium has been recognized, especially in developing countries.2-4 Of 113 cases of aseptic CVT seen in the past 20 years at the National Institute of Neurology and Neurosurgery in Mexico City, 67 were diagnosed in the puerperal period, 5 during pregnancy, and in 1 patient after abortion. The aim of this paper is to analyze these 67 cases and compare them with the remaining 46 cases of CVT, which were not related to obstetric causes, to disclose some clinical, paraclinical, or prognostic features that may be distinctive for patients with CVT associated with pregnancy and puerperium.
Subjects and Methods Patients with a diagnosis of aseptic CVT admitted to our hospital were included in this study when they satisfied any of the following criteria:
1. Angiographic evidence of CVT5,6: total or partial lack of filling of at least one sinus on at least two projections. When the lack of filling involved only the anterior portion of the superior sagittal sinus or only one lateral sinus, additional signs of CVT were required, such as evidence of delayed venous emptying or development of collateral circulation.
2. Evidence of CVT via neuropathological study: presence of thrombosis of venous sinuses or cerebral veins, with or without associated venous infarction.
3. Magnetic resonance imaging (MRI) evidence of CVT7: absence of voiding on TI weighted images with isointensity or hypointensity on T2 weighted images during the first few days and hyperintensity of the lumen of the sinus on T1 and T2 weighted images from about 1 week to 1 month after thrombosis.
Patients were excluded when (1) clinical or radiological records were incomplete, (2) radiological studies were inconclusive, (3) there was cavernous sinus thrombosis, or (4) CVT was associated with sepsis. Of 67 patients with CVT associated with pregnancy and puerperium (group 1), 50 were included on the basis of angiographic criteria, 10 by MRI criteria, and 7 by neuropathological criteria. Of the 46 cases with CVT unrelated to obstetric events (group 2), 26 were included on the basis of angiographic criteria, 11 by neuropathological criteria, and 9 by MRI criteria.
The following characteristics were compared between the two groups: Regarding puerperal patients, 21 cases of CVT (34.4%) occurred during the first week after delivery (9 within the first 48 hours) and 36 (59%) during weeks 2 and 3 postpartum. Pregnant patients were affected in any trimester (1 in the first, 2 in the second, and 2 in the third trimester). In group 1, there were 43 multiparas (64.1%), 36 women (53.7%) from low or rural social stratum, and 21 women (31.3%) whose delivery was conducted at home by midwives and who did not have proper prenatal care. Three patients had a history of venous thrombosis outside the central nervous system during previous pregnancies (two instances of pelvic venous thrombosis and 1 case of pulmonary embolism).
Patients from group 2 had the following predisposing factors for CVT: use of oral contraceptives (7 patients), thrombocytosis in 4 patients, secondary polycythemia in 3 cases, circulating lupus anticoagulant in 2, and protein S deficiency in 2. In addition, an arteriovenous malformation was present in 2 patients and metastatic carcinoma in 1. In the remaining 25 There were no differences between groups regarding sites of thrombosis within the cerebral venous system (Table 7) . Discussion A wide variety of well-known conditions may cause or predispose to CVT, and their relative importance may vary in different areas of the world.9-14 In the present study. 60% of cases were associated with pregnancy and puerperium (ratio group 1/group 2, 1.5). This complication is also common in India, with a prevalence of 4.5/1000 obstetric admissions.2.15 In accordance with an obstetric CVT series,16 symptoms of CVT appeared in the first 3 weeks after delivery in the majority of cases and, as in the Indian series, women who had home deliveries and poor prenatal care were more often affected. CVT should be suspected in any woman who develops neurological symptoms in the immediate postpartum period, since nearly 15% of our cases occurred in the first 2 days after a normal childbirth. CVT occurred 13 times more often during puerperium than during pregnancy. Although in the Indian population, multiparas are more often affected than primiparas, in a proportion of 4: 1,17 in our population this difference was not so striking (1.8:1) .
In this study, we found a high frequency (70%) of parenchymal lesions (venous infarcts and intracerebral hemorrhages) that manifested as focal neurological signs, epileptic seizures, disorders of consciousness, intracranial hypertension, nuchal rigidity, and hemorrhagic CSF. These findings also explain the high mortality rate in our whole series (18.5%) . This is in contrast with reports from other countries18-20 and illustrates the great clinical and neuroradiological pleomorphism of this condition worldwide. Our series is characterized by a low frequency of isolated intracranial hypertension and absence of Behcet's disease as a cause of CVT. Even when we consider these variations, there seem to be important differences be- Although the disease was of similar severity in both groups, the outcome was more favorable in obstetric patients. Possibly, CVT in obstetric subjects is a more benign entity than the one affecting other types of patients because of a more limited and transient occlusion, with rapid sinovenous recanalization by spontaneous thrombolysis or development of collaterals. Prognosis and treatment are the most controversial issues of cerebral venous thrombosis. Prognosis is quite variable. The outcome can range from total recovery to death. Since the introduction of MRI, an increasing number of patients with a benign course of CVT have been diagnosed.28 '29 Conversely, the benefit of anticoagulation now appears well established.89 It would be of paramount importance to be able to identify the benign cases that will recover completely whatever the treatment and the severe cases that would justify the risk of anticoagulation. Based on the experience acquired at our institution, we do not recommend anticoagulation in patients without the factors associated with a bad prognosis.30
